Business Context and Reporting Period
This Form 8-K is a current report filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on January 7, 2015. The filing reports an upcoming corporate event rather than financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to an announcement of a conference presentation.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The sole event reported is the scheduling of a management presentation.
Guidance, Outlook, and Management Commentary
Upcoming Presentation: CEO Antonius Schuh, Ph.D., is scheduled to provide an update on the Company's progress at the Biotech Showcase 2015 conference.
- Date: Monday, January 12, 2015
- Time: 9:30 a.m. PST
- Location: Parc 55 Wyndam Hotel, San Francisco, California (D track - Powell room)
The filing includes a press release as Exhibit 99.1 but contains no specific financial guidance or risk factors within the body of this 8-K.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific details on the company's progress.
- Confirm attendance or access to the Biotech Showcase 2015 presentation on January 12, 2015.
- Note that this filing contains no audited financial data; refer to the most recent 10-K or 10-Q for financial metrics.